ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Innovent and Chi-Med expand global collaboration for solid tumor treatment
October 10, 2019Preclinical studies have suggested that surufatinib is able to inhibit angiogenesis, block the accumulation of tumor associated macrophages and promote infiltration of effector T cells into tumors, all of which could contribute to improve anti-tumor activ
Pharma Sources Insight January 2025
